Get the Stockscreener App
13.97
20.33%
2.36
Pre-market:
13.94
-0.03
-0.21%
Apollomics Inc stock is traded at $13.97, with a volume of 97,350.
It is up +20.33% in the last 24 hours and down -24.21% over the past month.
Apollomics Inc is an clinical-stage biopharmaceutical company focused on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. The company programs include vebreltinib (APL-101), a potent, selective c-Met inhibitor for the treatment of non-small cell lung cancer and other tumors with c-Met alterations, and uproleselan (APL-106), a specific E-Selectin antagonist that has the potential to be used adjunctively with standard chemotherapy to treat acute myeloid leukemia.
See More
Previous Close:
$11.61
Open:
$11.51
24h Volume:
97,350
Relative Volume:
1.41
Market Cap:
$15.41M
Revenue:
-
Net Income/Loss:
$-53.86M
P/E Ratio:
-0.2565
EPS:
-54.4704
Net Cash Flow:
$-28.76M
1W Performance:
-39.26%
1M Performance:
-24.21%
6M Performance:
+111.99%
1Y Performance:
+17.49%
1-Day Range:
$11.51
$17.30
1-Week Range:
$10.01
$27.72
52-Week Range:
$3.659
$42.12
Apollomics Inc Stock (APLM) Company Profile
Compare APLM with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
APLM
Apollomics Inc
|
13.97 | 24.88M | 0 | -53.86M | -28.76M | -54.47 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Apollomics Inc Stock (APLM) Latest News
Why Lucas GC Shares Are Trading Higher By Over 36%; Here Are 20 Stocks Moving Premarket - Benzinga
How Apollomics Inc. Equity Warrant stock reacts to bond yields2025 Sector Review & Growth Focused Stock Pick Reports - newser.com
Published on: 2025-11-03 02:28:00 - newser.com
Is Apollomics Inc. stock positioned for long term growthJuly 2025 Intraday Action & Long-Term Investment Growth Plans - newser.com
Apollomics Inc. Equity Warrant recovery potential after sell offQuarterly Risk Review & Accurate Entry and Exit Point Alerts - newser.com
Is Apollomics Inc. Equity Warrant stock a bargain at current levelsIPO Watch & Risk Managed Investment Strategies - newser.com
Volume spikes in Apollomics Inc. Equity Warrant stock – what they meanJuly 2025 PreEarnings & Free Fast Entry Momentum Trade Alerts - newser.com
Volume spikes in Apollomics Inc. stock – what they meanDay Trade & Smart Allocation Stock Tips - newser.com
What Fibonacci levels say about Apollomics Inc. reboundQuarterly Trade Report & Daily Stock Trend Reports - newser.com
Is Apollomics Inc. Equity Warrant stock a top momentum playJuly 2025 Weekly Recap & Weekly High Potential Alerts - newser.com
Applying Elliott Wave Theory to Apollomics Inc.Weekly Stock Summary & Verified Entry Point Signals - newser.com
Why Apollomics Inc. Equity Warrant stock is popular among millennialsEarnings Trend Report & Trade Opportunity Analysis Reports - newser.com
What to do if you’re stuck in Apollomics Inc.CPI Data & Reliable Breakout Forecasts - newser.com
Building trade automation scripts for Apollomics Inc.Portfolio Value Summary & AI Forecasted Entry and Exit Points - newser.com
Will Apollomics Inc. Equity Warrant stock recover after recent dropRecession Risk & Real-Time Market Trend Scan - newser.com
Using Python tools to backtest Apollomics Inc. strategiesWeekly Earnings Recap & Capital Protection Trading Alerts - newser.com
Is a relief rally coming for Apollomics Inc. holdersPortfolio Value Summary & Weekly Consistent Profit Watchlists - newser.com
Can Apollomics Inc. stock continue upward trend2025 Technical Overview & Daily Stock Trend Watchlist - newser.com
Sentiment analysis tools applied to Apollomics Inc.2025 Breakouts & Breakdowns & Growth Focused Stock Pick Reports - newser.com
How Apollomics Inc. stock compares to market leadersQuarterly Growth Report & AI Forecast Swing Trade Picks - newser.com
Full technical analysis of Apollomics Inc. Equity Warrant stockQuarterly Profit Summary & Safe Investment Capital Preservation Plans - newser.com
Is Apollomics Inc. Equity Warrant a candidate for recovery playInsider Buying & Short-Term Trading Alerts - newser.com
Published on: 2025-10-30 23:36:21 - newser.com
Apollomics Inc Stock (APLM) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.62%
0.21%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):